Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $51,765 - $70,380
750 New
750 $52,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $16,382 - $18,956
189 Added 27.19%
884 $76,000
Q1 2023

May 15, 2023

SELL
$87.74 - $117.27 $62,646 - $83,730
-714 Reduced 50.67%
695 $67,000
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $76,573 - $90,348
932 Added 195.39%
1,409 $11.9 Million
Q2 2022

Aug 15, 2022

BUY
$71.48 - $86.85 $10,722 - $13,027
150 Added 45.87%
477 $3.95 Million
Q1 2022

May 16, 2022

BUY
$74.28 - $92.69 $24,289 - $30,309
327 New
327 $2.52 Million
Q3 2020

Nov 16, 2020

SELL
$71.87 - $131.03 $3.92 Million - $7.14 Million
-54,500 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$79.55 - $124.22 $2.77 Million - $4.32 Million
34,800 Added 176.65%
54,500 $6.72 Million
Q4 2019

Feb 14, 2020

SELL
$64.27 - $86.37 $661,981 - $889,611
-10,300 Reduced 34.33%
19,700 $1.67 Million
Q3 2019

Nov 14, 2019

SELL
$67.4 - $85.11 $1.53 Million - $1.93 Million
-22,700 Reduced 43.07%
30,000 $2.02 Million
Q1 2019

May 15, 2019

BUY
$84.2 - $98.62 $421,000 - $493,100
5,000 Added 10.48%
52,700 $4.68 Million
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $3.82 Million - $5.06 Million
47,700 New
47,700 $4.06 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Deep Currents Investment Group LLC Portfolio

Follow Deep Currents Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Currents Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Deep Currents Investment Group LLC with notifications on news.